English | Español
Patient Daily | Dec 9, 2025

Penn Medicine appoints new leaders aiming to reshape undergraduate and graduate medical education
Patient Daily | Dec 9, 2025

Prasad memo prompts debate as FDA sees leadership changes and new drug data emerges
Patient Daily | Dec 9, 2025

Bristol Myers Squibb postpones Alzheimer’s psychosis drug trial results after site irregularities
Patient Daily | Dec 9, 2025

UTHealth Houston researchers secure nearly $10 million for diverse state-backed cancer initiatives
Patient Daily | Dec 9, 2025

International Arthritis Foundation urges changes to 340B drug pricing program
Patient Daily | Dec 9, 2025

Early-stage biotech firms urged to address tariff risks in planning
Patient Daily | Dec 9, 2025

Harmony's EPX-100 reduces seizures by half in Dravet syndrome Phase III trial
Patient Daily | Dec 9, 2025

Pharma explores learning from China's R&D efficiencies amid growing licensing deals

Trending
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Amgen declines FDA request to withdraw rare disease drug Tavneos
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Danish medtech firm OSAA Innovation brings connected IV solutions to WHX Dubai 2026
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

Corcept reports positive Phase III results for ovarian cancer drug relacorilant